Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 6, 2023
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
[ Wed, Sep 06th 2023
] - WOPRAI
Asthika Goonewardene Reiterated (STRO) at Strong Buy and Held Target at $25 on, Sep 6th, 2023
Asthika Goonewardene of Truist Securities, Reiterated "Sutro Biopharma, Inc." (STRO) at Strong Buy and Held Target at $25 on, Sep 6th, 2023.
Asthika has made no other calls on STRO in the last 4 months.
There are 3 other peers that have a rating on STRO. Out of the 3 peers that are also analyzing STRO, 0 agree with Asthika's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Asthika
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $17 on, Monday, August 14th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $16 on, Friday, August 11th, 2023
- David Nierengarten of "Wedbush" Maintained at Buy with Decreased Target to $12 on, Friday, August 11th, 2023
